No increase in C-reactive protein levels during intranasal compared to oral hormone therapy in healthy post-menopausal women

Author： Hemelaar M.   Kenemans P.   Schalkwijk C.G.   Braat D.D.M.   van der Mooren M.J.  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.21, Iss.6, 2006-06, pp. : 1635-1642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association of serum complement (C3, C4) and immunoglobulin (IgG, IgM) levels with hormone replacement therapy in healthy post‐menopausal women

By Yilmazer Mehmet  

Human Reproduction, Vol. 18, Iss. 7, 2003-07 ,pp. : 1531-1535

Oxford University Press

Access to resources Recommend Favorite

Effects of tibolone and combined 17-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial

By Garnero Patrick  

Human Reproduction, Vol. 17, Iss. 10, 2002-10 ,pp. : 2748-2753

Oxford University Press

Access to resources Recommend Favorite

The levels of C‐reactive protein in women treated by IVF

By Almagor Miriam  

Human Reproduction, Vol. 19, Iss. 1, 2004-01 ,pp. : 104-106

Oxford University Press

Access to resources Recommend Favorite

Effects of short‐term transdermal hormone replacement therapy on glycaemic control, lipid metabolism, C‐reactive protein and proteinuria in postmenopausal women with type 2 diabetes or hypertension

By Fenkci Semin  

Human Reproduction, Vol. 18, Iss. 4, 2003-04 ,pp. : 866-870

Oxford University Press

Access to resources Recommend Favorite

Immune effects of hormone replacement therapy in post-menopausal women

By Porter V.R.   Greendale G.A.   Schocken M.   Zhu X.   Effros R.B.  

Experimental Gerontology, Vol. 36, Iss. 2, 2001-02 ,pp. : 311-326

Elsevier

Access to resources Recommend Favorite